View in EDS

Dabrafenib plus trametinib vs encorafenib plus binimetinib in BRAF -mutant metastatic melanoma: a real-world propensity score–matched survival analysis.

Saved in:
Bibliographic Details
Title: Dabrafenib plus trametinib vs encorafenib plus binimetinib in BRAF -mutant metastatic melanoma: a real-world propensity score–matched survival analysis.
Authors: Garitaonaindia, Yago1 (AUTHOR), Khan, Shawez1 (AUTHOR), Friis, Rasmus2 (AUTHOR), Kjær, Søren3 (AUTHOR), Borch, Troels H1 (AUTHOR), Ruhlmann, Christina3 (AUTHOR), Guldbrandt, Louise M2 (AUTHOR), Luczak, Adam A4 (AUTHOR), Schmidt, Henrik2 (AUTHOR), Bastholt, Lars3 (AUTHOR)
Source: JNCI: Journal of the National Cancer Institute. Feb2026, Vol. 118 Issue 2, p261-268. 8p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 191546964
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Dabrafenib plus trametinib vs encorafenib plus binimetinib in BRAF -mutant metastatic melanoma: a real-world propensity score–matched survival analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Garitaonaindia%2C+Yago%22">Garitaonaindia, Yago</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Khan%2C+Shawez%22">Khan, Shawez</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Friis%2C+Rasmus%22">Friis, Rasmus</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kjær%2C+Søren%22">Kjær, Søren</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Borch%2C+Troels+H%22">Borch, Troels H</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ruhlmann%2C+Christina%22">Ruhlmann, Christina</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Guldbrandt%2C+Louise+M%22">Guldbrandt, Louise M</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Luczak%2C+Adam+A%22">Luczak, Adam A</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schmidt%2C+Henrik%22">Schmidt, Henrik</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bastholt%2C+Lars%22">Bastholt, Lars</searchLink><relatesTo>3</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22JNCI%3A+Journal+of+the+National+Cancer+Institute%22">JNCI: Journal of the National Cancer Institute</searchLink>. Feb2026, Vol. 118 Issue 2, p261-268. 8p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=191546964
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/jnci/djaf263
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 8
        StartPage: 261
    Titles:
      – TitleFull: Dabrafenib plus trametinib vs encorafenib plus binimetinib in BRAF -mutant metastatic melanoma: a real-world propensity score–matched survival analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Garitaonaindia, Yago
      – PersonEntity:
          Name:
            NameFull: Khan, Shawez
      – PersonEntity:
          Name:
            NameFull: Friis, Rasmus
      – PersonEntity:
          Name:
            NameFull: Kjær, Søren
      – PersonEntity:
          Name:
            NameFull: Borch, Troels H
      – PersonEntity:
          Name:
            NameFull: Ruhlmann, Christina
      – PersonEntity:
          Name:
            NameFull: Guldbrandt, Louise M
      – PersonEntity:
          Name:
            NameFull: Luczak, Adam A
      – PersonEntity:
          Name:
            NameFull: Schmidt, Henrik
      – PersonEntity:
          Name:
            NameFull: Bastholt, Lars
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: Feb2026
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 00278874
          Numbering:
            – Type: volume
              Value: 118
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: JNCI: Journal of the National Cancer Institute
              Type: main
ResultId 1